Journal of Neoplasms

Journal of Neoplasms Membership

Advancing cancer research from discovery to cure.

Unite in the Fight Against Cancer

The Journal of Neoplasms brings together oncologists, cancer biologists, translational researchers, and clinical investigators worldwide. Membership connects you to a global community dedicated to understanding and defeating malignancy through rigorous science.

Every breakthrough begins with shared knowledge—join us in transforming cancer care.

Membership Tiers
RESEARCHER

Individual Member

$229/year
  • 15% discount on article processing charges
  • Priority manuscript handling
  • Monthly oncology research digest
  • Access to member-only webinars
  • Digital membership certificate
  • Profile listing in member directory
CONSORTIUM

Institutional Member

$1,799/year
  • 30% APC discount for all affiliates
  • Unlimited author registrations
  • Centralized billing arrangements
  • Dedicated account management
  • Custom usage analytics dashboard
  • Priority technical support access
Why Join Our Community?

Breakthrough Research

Access cutting-edge discoveries in tumor biology, immunotherapy, precision oncology, and emerging therapeutic modalities shaping the future of cancer treatment.

Global Network

Connect with oncologists, cancer researchers, pharmaceutical scientists, and clinical trialists from leading cancer centers, academic institutions, and biotech companies worldwide.

Publication Advantages

Benefit from reduced APCs, faster review timelines, and enhanced visibility for your published work through member promotion and featured article programs.

Career Development

Gain recognition through editorial opportunities, invited reviews, speaking invitations, and annual awards honoring outstanding contributions to cancer research.

Research Focus Areas

Tumor Biology & Genetics

Driver mutations, cancer genomics, tumor heterogeneity, metastasis mechanisms, and the molecular basis of malignant transformation and progression.

Immunotherapy & Cell Therapy

CAR-T cells, checkpoint inhibitors, cancer vaccines, adoptive cell transfer, and novel strategies harnessing immune systems against tumors.

Precision Oncology

Biomarker-driven therapy, companion diagnostics, liquid biopsy, pharmacogenomics, and personalized treatment strategies for individual patients.

Clinical Translation

Drug development pipelines, clinical trial design, real-world evidence, survivorship research, and implementation of evidence-based cancer care.

Member Benefits

Accelerating Discovery: From manuscript preparation to post-publication amplification, we help maximize the reach and impact of your oncology research through comprehensive author services and strategic dissemination to the cancer research community.

  • Reduced Publication Fees: Significant APC discounts reduce financial barriers to Open Access publishing
  • Faster Processing: Priority handling moves your manuscript through expert review efficiently
  • Networking Events: Virtual seminars and annual conferences facilitate collaborative opportunities
  • Educational Resources: Exclusive webinars on methodology, statistics, and research communication
  • Recognition Programs: Annual awards honoring transformative contributions to cancer science

For membership inquiries or institutional partnerships, contact [email protected]. Together, we advance the science that saves lives.

Join the Cancer Research Community

Be part of the global effort transforming oncology through science.

Your research could change the future of cancer care—share it today.